Last edition
News about Industrial talks
Helex Raises USD 3.5 Million in Seed Round to Advance Non-Viral Gene Therapies for Kidney Diseases
The new funding will support the development of Helex’s lead programme for ADPKD toward IND enabling studies, pipeline expansion leveraging its programmable LNP delivery and AI-based drug design platforms. The company is steadfast in building a robust franchise of renal programmes that profoundly improve and impact the lives of patients.
Industrial talks | 01/11/2025 | By Dineshwori | 269
Cipla Elevates Achin Gupta as Next Managing Director and Global CEO
Cipla has announced the elevation of Achin Gupta as its next Managing Director and Global Chief Executive Officer, effective April 1, 2026. Currently serving as the company’s Global Chief Operating Officer, Gupta will take over from Umang Vohra, who will step down upon completion of his term on March 31, 2026.
Industrial talks | 30/10/2025 | By Dineshwori | 371
Sanofi India Names Deepak Arora as MD Starting October 27, 2025
Approved by Sanofi India’s Board, the appointment places Deepak Arora in charge of steering the company’s strategic priorities and operations in line with its global vision.
Industrial talks | 28/10/2025 | By Dineshwori | 246
Eli Lilly Acquires Adverum to Embolden Gene-Therapy Eye-Care Ambitions
Eli Lilly has announced that it will acquire gene therapy developer Adverum Biotechnologies in a deal valued at up to USD 261.7 million, signalling a push into the ophthalmology space.
Industrial talks | 27/10/2025 | By Darshana | 198
Alchem International Appeals to Delhi High Court against Single-Judge Order Banning 'Alchem' Use
The injunction prohibits Alchem from using its name in connection with medicines or medicinal products until further orders. Alchem’s appeal seeks to overturn the interim ban and restore its ability to use its brand amidst the ongoing trademark dispute.
Industrial talks | 17/10/2025 | By Darshana | 249
Aragen Appoints Neeraj Garg as CEO to Bolster Discovery Leadership
In this role at Aragen, Neeraj Garg will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base.
Industrial talks | 16/10/2025 | By Dineshwori | 301
Balaji Amines Under Scrutiny for Producing Pharma-Grade Chemical Without Valid Licence
Indian authorities have accused Balaji Amines of manufacturing pharmaceutical-grade propylene glycol (PG) without possessing the necessary drug manufacturing licence, after certain test batches were reportedly found to be substandard.
Industrial talks | 15/10/2025 | By Darshana | 381
Natco Pharma to Acquire 35.75 Percent Stake in South Africa's Adcock Ingram, Delisting Planned
Natco Pharma has announced its intention to acquire a 35.75 percent equity stake in South Africa’s Adcock Ingram Holdings, in a deal valued at approximately INR 2,000 crore. This transaction is expected to make Natco the second-largest shareholder, while Bidvest will retain a 64.25 percent holding.
Industrial talks | 13/10/2025 | By Darshana | 391
Through a novel public-private partnership, IAVI, Minapharm and ProBioGen will work together to bolster the innovation ecosystem on the continent and enable sustainable access to urgently-needed products.
Industrial talks | 13/10/2025 | By Dineshwori | 159
Kazia Therapeutics Limited, a Sydney-based oncology-focused drug development company, has entered into an exclusive collaboration and in-licensing agreement with QIMR Berghofer to advance a pioneering PD-L1 degrader programme.
Industrial talks | 11/10/2025 | By Darshana | 193
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy